CAS 98902-29-5
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
2,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:Formula:C19H24ClN5O4Purity:95%Color and Shape:SolidMolecular weight:421.8780N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloridePurity:95%Molecular weight:421.89g/molN-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]furan-2-carboxamide Hydrochloride
CAS:Color and Shape:Neat2,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:<p>Impurity Alfuzosin EP Impurity A / Alfuzosin USP Related Compound A<br>Stability Hygroscopic<br>Applications 2,3,4,5-Tetradehydro Alfuzosin Hydrochloride (Alfuzosin EP Impurity A) is an impurity of Alfuzosin (A532010) . Alfuzosin (A532010) is an α1-adrenoceptor antagonist with antihypertensive activity.<br>References Manoury, P.M. et al.: J. Med. Chem., 29, 19 (1986);<br></p>Formula:C19H23N5O4·ClHColor and Shape:NeatMolecular weight:421.882,3,4,5-Tetradehydro alfuzosin hydrochloride
CAS:<p>Alfuzosin is a potent, selective, and long-acting α1A-adrenergic receptor antagonist. It is used to treat benign prostatic hyperplasia (BPH) in males. Alfuzosin is also used as an antihypertensive agent, for the treatment of pheochromocytoma, and for the treatment of benign prostatic hyperplasia in males. The hydrogenation of 2,3,4,5-tetradehydroalfuzosin to alfuzosin hydrochloride is performed by liquid hydrogenation or by hydrogenation on a palladium catalyst in a mixture of dimethylformamide and hexamethylphosphoramide. This process minimizes the formation of impurities such as 2,3,4-trimethoxy alfuzosin.</p>Formula:C19H24ClN5O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:421.88 g/mol
![N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]furan-2-carboxamide Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM1004.01-0025.jpg&w=3840&q=75)
